『82. Optimal Duration of MOUD (Medications for Opioid Use Disorder)』のカバーアート

82. Optimal Duration of MOUD (Medications for Opioid Use Disorder)

82. Optimal Duration of MOUD (Medications for Opioid Use Disorder)

無料で聴く

ポッドキャストの詳細を見る
We discuss an article about the benefits of continuing buprenorphine, methadone, and naltrexone long-term. Hayes CJ, Raciborski RA, Acharya M, Noor NB, Nunes EV, Winhusen TJ. Evaluating the optimal duration of medication treatment for opioid use disorder. Addiction. 2026 Apr;121(4):922-933. doi: 10.1111/add.70211. Epub 2026 Jan 7. PMID: 41501983; PMCID: PMC12980296. We also discuss increasing reimbursement for smoking cessation counselling, and VA trials of GLP-1s for alcohol use disorder. StatNews: Quitting smoking is hard. A Medicare change may push doctors to give more help Medicare proposed 2027 fee schedule (a little light reading) To make public comments on the 2027 fee schedule Military Times: VA launches trial to test GLP-1 medication for alcohol use disorder in veterans --- This podcast offers category 1 and MATE-ACT CME credits through MI CARES and Michigan State University. To get credit for this episode and others, go to this link to make your account, take a brief quiz, and claim your credit. To learn more about opportunities in addiction medicine, visit MI CARES. CME: https://micaresed.org/courses/podcast-addiction-medicine-journal-club/ --- Original theme music: composed and performed by Benjamin Kennedy Audio editing: Michael Bonanno Executive producer: Dr. Patrick Beeman A podcast from Ars Longa Media --- This is Addiction Medicine Journal Club with Dr. Sonya Del Tredici and Dr. John Keenan. We practice addiction medicine and primary care, and we believe that addiction is a disease that can be treated. This podcast reviews current articles to help you stay up to date with research that you can use in your addiction medicine practice. The best part of any journal club is the conversation. Send us your comments on social media or join our Facebook group. --- Email: addictionmedicinejournalclub@gmail.com Facebook: @AddictionMedJC Facebook Group: Addiction Medicine Journal Club Instagram: @AddictionMedJC Threads: @AddictionMedJC YouTube: addictionmedicinejournalclub Twitter/X: @AddictionMedJC --- Addiction Medicine Journal Club is intended for educational purposes only and should not be considered medical advice. The views expressed here are our own and do not necessarily reflect those of our employers or the authors of the articles we review. All patient information has been modified to protect their identities. Learn more about your ad choices. Visit megaphone.fm/adchoices
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません